The Vanguard Group 13D/13G Filings for Daré Bioscience, Inc. (DARE)

The Vanguard Group 13D and 13G filings for Daré Bioscience, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2022-02-09
3:43 pm
Purchase		2021-12-3113GDaré Bioscience, Inc.
DARE		The Vanguard Group254,671
3.990%		5,232increase
(+2.10%)		Filing
2021-02-10
10:46 am
Purchase		2020-12-3113GDaré Bioscience, Inc.
DARE		The Vanguard Group249,440
7.880%		249,440increase
(New Position)		Filing